Drug Enforcement Administration 2013 – Federal Register Recent Federal Regulation Documents

Results 151 - 200 of 243
Manufacturer of Controlled Substances; Notice of Registration; Siegfried (Usa), Llc.
Document Number: 2013-12116
Type: Notice
Date: 2013-05-22
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances, Notice of Application, Austin Pharma, Llc.
Document Number: 2013-12115
Type: Notice
Date: 2013-05-22
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application; Alltech Associates, Inc.
Document Number: 2013-12114
Type: Notice
Date: 2013-05-22
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances, Notice of Application, Lin Zhi International, Inc.
Document Number: 2013-12110
Type: Notice
Date: 2013-05-22
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances, Notice of Application
Document Number: 2013-12109
Type: Notice
Date: 2013-05-22
Agency: Drug Enforcement Administration, Department of Justice
Schedules of Controlled Substances: Temporary Placement of Three Synthetic Cannabinoids Into Schedule I
Document Number: 2013-11593
Type: Rule
Date: 2013-05-16
Agency: Drug Enforcement Administration, Department of Justice
The Deputy Administrator of the Drug Enforcement Administration (DEA) is issuing this final order to temporarily schedule three synthetic cannabinoids under the Controlled Substances Act (CSA) pursuant to the temporary scheduling provisions of 21 U.S.C. 811(h). The substances are (1-pentyl-1H-indol-3-yl)(2,2,3,3- tetramethylcyclopropyl)methanone (UR-144), [1-(5-fluoro-pentyl)-1H- indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone (5-fluoro-UR-144, XLR11) and N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide (APINACA, AKB48). This action is based on a finding by the Deputy Administrator that the placement of these synthetic cannabinoids and their salts, isomers and salts of isomers into Schedule I of the CSA is necessary to avoid an imminent hazard to the public safety. As a result of this order, the full effect of the CSA and the Controlled Substances Import and Export Act (CSIEA) and their implementing regulations including criminal, civil and administrative penalties, sanctions and regulatory controls of Schedule I substances will be imposed on the manufacture, distribution, possession, importation, and exportation of these synthetic cannabinoids.
Leo A. Farmer, M.D.; Decision and Order
Document Number: 2013-11268
Type: Notice
Date: 2013-05-13
Agency: Drug Enforcement Administration, Department of Justice
Jose G. Zavaleta, M.D.; Decision and Order
Document Number: 2013-11185
Type: Notice
Date: 2013-05-10
Agency: Drug Enforcement Administration, Department of Justice
Schedules of Controlled Substances: Placement of Lorcaserin Into Schedule IV
Document Number: 2013-10895
Type: Rule
Date: 2013-05-08
Agency: Drug Enforcement Administration, Department of Justice
With the issuance of this final rule, the Administrator of the Drug Enforcement Administration (DEA) places the substance lorcaserin, including its salts, isomers and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible, into Schedule IV of the Controlled Substances Act (CSA). This action is pursuant to the CSA which requires that such actions be made on the record after opportunity for a hearing through formal rulemaking.
Top RX Pharmacy; Decision and Order
Document Number: 2013-10550
Type: Notice
Date: 2013-05-03
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances, Notice of Application, Lipomed
Document Number: 2013-09538
Type: Notice
Date: 2013-04-23
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances: Notice of Registration; Fisher Clinical Services, Inc.
Document Number: 2013-09537
Type: Notice
Date: 2013-04-23
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application; Wildlife Laboratories, Inc.
Document Number: 2013-09535
Type: Notice
Date: 2013-04-23
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application; Research Triangle Institute
Document Number: 2013-09533
Type: Notice
Date: 2013-04-23
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration; S & B Pharma Inc.
Document Number: 2013-09532
Type: Notice
Date: 2013-04-23
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration; Alltech Associates, Inc.
Document Number: 2013-09531
Type: Notice
Date: 2013-04-23
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration; Cayman Chemical Company
Document Number: 2013-09530
Type: Notice
Date: 2013-04-23
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration; PCAS-Nanosyn, LLC
Document Number: 2013-09529
Type: Notice
Date: 2013-04-23
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances, Notice of Application, Navinta, LLC
Document Number: 2013-09318
Type: Notice
Date: 2013-04-19
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application; Penick Corporaton
Document Number: 2013-09317
Type: Notice
Date: 2013-04-19
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances, Notice of Application, American Radiolabeled Chemicals, Inc.
Document Number: 2013-09315
Type: Notice
Date: 2013-04-19
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Application; Rhodes Technologies
Document Number: 2013-09305
Type: Notice
Date: 2013-04-19
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances, Notice of Application, Almac Clinical Services, Inc., (ACSI)
Document Number: 2013-09302
Type: Notice
Date: 2013-04-19
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Registration
Document Number: 2013-09299
Type: Notice
Date: 2013-04-19
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Application; Catalent CTS., Inc.
Document Number: 2013-09293
Type: Notice
Date: 2013-04-19
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Registration; GE Healthcare
Document Number: 2013-09290
Type: Notice
Date: 2013-04-19
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances, Notice of Application, Rhodes Technologies
Document Number: 2013-09283
Type: Notice
Date: 2013-04-19
Agency: Drug Enforcement Administration, Department of Justice
Schedules of Controlled Substances: Placement of Methylone Into Schedule I
Document Number: 2013-08673
Type: Rule
Date: 2013-04-12
Agency: Drug Enforcement Administration, Department of Justice
With the issuance of this final rule, the Administrator of the Drug Enforcement Administration (DEA) places the substance 3,4- methylenedioxy-N-methylcathinone (methylone) including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible, into Schedule I of the Controlled Substances Act (CSA). This action is pursuant to the CSA which requires that such actions be made on the record after opportunity for a hearing through formal rulemaking.
Schedules of Controlled Substances: Temporary Placement of Three Synthetic Cannabinoids Into Schedule I
Document Number: 2013-08671
Type: Proposed Rule
Date: 2013-04-12
Agency: Drug Enforcement Administration, Department of Justice
The Deputy Administrator of the Drug Enforcement Administration (DEA) is issuing this notice of intent to temporarily schedule three synthetic cannabinoids into the Controlled Substances Act (CSA) pursuant to the temporary scheduling provisions of 21 U.S.C. 811(h). The substances are 1-pentyl-1H-indol-3-yl)(2,2,3,3- tetramethylcyclopropyl)methanone (UR-144), 1-(5-fluoro-pentyl)-1H- indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone (5-fluoro-UR-144; XLR11) and N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide (APINACA, AKB48). This action is based on a finding by the Deputy Administrator that the placement of these synthetic cannabinoids into Schedule I of the CSA is necessary to avoid an imminent hazard to the public safety. Any final order will be published in the Federal Register and may not be issued prior to May 13, 2013. Any final order will impose the administrative, civil, and criminal sanctions and regulatory controls of Schedule I substances under the CSA on the manufacture, distribution, possession, importation, and exportation of these synthetic cannabinoids.
Pawan Kumar Jain, M.D.; Decision And Order
Document Number: 2013-07195
Type: Notice
Date: 2013-03-28
Agency: Drug Enforcement Administration, Department of Justice
Gary Alfred Shearer, M.D.; Decision And Order
Document Number: 2013-07194
Type: Notice
Date: 2013-03-28
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Application; SA INTL GMBH C/O., Sigma Aldrich Co. LLC
Document Number: 2013-07152
Type: Notice
Date: 2013-03-28
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Registration; Johnson Matthey, Inc.
Document Number: 2013-07150
Type: Notice
Date: 2013-03-28
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Application; Stepan Company
Document Number: 2013-07147
Type: Notice
Date: 2013-03-28
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Registration; Mylan Pharmaceuticals, Inc.
Document Number: 2013-07143
Type: Notice
Date: 2013-03-28
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration; Siemens Healthcare Diagnostics, Inc.
Document Number: 2013-07141
Type: Notice
Date: 2013-03-28
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application; Johnson Matthey Pharmaceutical Materials, Inc.
Document Number: 2013-07140
Type: Notice
Date: 2013-03-28
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application; Patheon Pharmaceuticals, Inc.
Document Number: 2013-07138
Type: Notice
Date: 2013-03-28
Agency: Drug Enforcement Administration, Department of Justice
Electronic Prescriptions for Controlled Substances Notice of Approved Certification Process
Document Number: 2013-06918
Type: Notice
Date: 2013-03-26
Agency: Drug Enforcement Administration, Department of Justice
DEA is announcing two new DEA-approved certification processes for providers of Electronic Prescriptions for Controlled Substances (EPCS) applications. Certifying organizations with a certification process approved by DEA pursuant to 21 Code of Federal Regulations (CFR) 1311.300(e) are posted on DEA's Web site upon approval.
Schedules of Controlled Substances: Placement of Alfaxalone into Schedule IV
Document Number: 2013-06651
Type: Proposed Rule
Date: 2013-03-25
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration (DEA) proposes the placement of 5[alpha]-pregnan-3[alpha]-ol-11,20-dione (alfaxalone) including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible, into Schedule IV of the Controlled Substances Act (CSA). This proposed action is pursuant to the CSA which requires that such actions be made on the record after opportunity for a hearing through formal rulemaking.
Manufacturer of Controlled Substances; Notice of Application: Morton Grove Pharmaceuticals
Document Number: 2013-06332
Type: Notice
Date: 2013-03-20
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances, Notice of Application, Noramco Inc.
Document Number: 2013-06330
Type: Notice
Date: 2013-03-20
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances, Notice of Registration, Watson Pharma, Inc.
Document Number: 2013-06328
Type: Notice
Date: 2013-03-20
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration: Noramco, Inc.
Document Number: 2013-06324
Type: Notice
Date: 2013-03-20
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances, Notice of Registration, Noramco, Inc.
Document Number: 2013-06321
Type: Notice
Date: 2013-03-20
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances, Notice of Application, United States Pharmacopeial Convention
Document Number: 2013-06318
Type: Notice
Date: 2013-03-20
Agency: Drug Enforcement Administration, Department of Justice